UroGen Pharma Ltd (URGN) — Financial Flexibility Index
UroGen Pharma Ltd (URGN) has a Financial Flexibility Index of -0.12x as of March 2026. Free cash flow of $-45.26 Million (operating CF $-45.32 Million minus capex $54.00K) represents 0% of total liabilities ($377.94 Million). Also explore URGN net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
UroGen Pharma Ltd Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for UroGen Pharma Ltd across 13 annual periods. Check URGN capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for UroGen Pharma Ltd (2013–2025)
Year-by-year free cash flow to debt coverage for UroGen Pharma Ltd. For the full company profile including market capitalisation, see URGN company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.53x | $-162.16 Million | $-162.44 Million | $305.93 Million | ▼ -61.8% |
| 2024 | -0.33x | $-96.47 Million | $-96.77 Million | $294.51 Million | ▼ -4.7% |
| 2023 | -0.31x | $-76.18 Million | $-76.38 Million | $243.52 Million | ▲ +19.4% |
| 2022 | -0.39x | $-87.31 Million | $-87.56 Million | $224.98 Million | ▲ +48.7% |
| 2021 | -0.76x | $-84.14 Million | $-84.89 Million | $111.33 Million | ▲ +81.5% |
| 2020 | -4.08x | $-104.67 Million | $-105.89 Million | $25.65 Million | ▼ -27.5% |
| 2019 | -3.20x | $-70.69 Million | $-71.02 Million | $22.09 Million | ▼ -17.2% |
| 2018 | -2.73x | $-36.77 Million | $-37.33 Million | $13.46 Million | ▼ -106.6% |
| 2017 | -1.32x | $-9.30 Million | $-9.57 Million | $7.04 Million | ▼ -282.7% |
| 2016 | 0.72x | $4.88 Million | $4.19 Million | $6.75 Million | ▲ +123.6% |
| 2015 | -3.07x | $-6.87 Million | $-7.17 Million | $2.24 Million | ▲ +33.1% |
| 2014 | -4.59x | $-4.09 Million | $-4.12 Million | $891.00K | ▲ +11.1% |
| 2013 | -5.17x | $-2.50 Million | $-2.56 Million | $484.00K | — |